← 返回列表 SCI 期刊 医学 Endokrynol Pol

Endokrynologia Polska

Endokrynol Pol

Print ISSN 0423-104X Online ISSN 2299-8306
SCIE Q3 新锐4区 开放获取 医学
影响因子 2026
2.2
↑ 0.1
5年均分
2.3
5-Year IF
H 指数
24
H-Index
年发文量
70
Articles / Year
出刊频率
Bimonthly
Pub. Frequency
创刊年份
1950
Founded Year
出版商
Via Medica
Publisher
出版国家
Poland
Country
投稿参考 & 用户评分
🏆 期刊声誉
暂无
综合口碑评分,点击星星参与
审稿速度
系统
暂无
2.8 个月
💰 版面费用
系统
暂无
官方APC $539 USD 约¥3,908
中科院分区
2026新锐分区 新体系
大类4区
医学Medicine
小类4区
内分泌学与代谢Endocrinology & Metabolism
中科院2025年分区 传统体系
大类4区
医学Medicine
小类4区
内分泌学与代谢Endocrinology & Metabolism
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q3
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
内分泌学与代谢 Endocrinology & Metabolism SCIE Q3 145/198
26.8%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
内分泌学与代谢 Endocrinology & Metabolism SCIE Q4 125/161 JCI 0.45
23.0%
Scopus 指标
CiteScore
2.9
综合引用得分
SJR
0.501 Q3
SCImago Journal Rank
SNIP
0.614
Source Normalized Impact
JCI
0.45
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Endokrynologia Polska (abbreviated as Endokrynol Pol) is a peer-reviewed scientific journal dedicated to the field of endocrinology. Published by the Polish Society of Endocrinology, the journal serves as a key platform for disseminating clinical and experimental research in this specialized medical discipline. Its scope encompasses a broad range of topics, including thyroid disorders, diabetes mellitus, pituitary and adrenal diseases, neuroendocrinology, reproductive endocrinology, metabolic bone disease, and hormonal aspects of oncology. The journal primarily publishes original research articles, comprehensive review articles, and concise clinical case reports, with occasional editorials and letters to the editor that stimulate academic discourse. The target audience includes endocrinologists, diabetologists, internal medicine specialists, and researchers in metabolic and hormonal sciences. Endokrynologia Polska is an open-access journal, ensuring that all published content is freely available to readers worldwide, which enhances the visibility and dissemination of its scientific contributions. With a 2026 Impact Factor of 2.2000, the journal is ranked in the JCR Q3 quartile, placing it within the lower-middle tier of endocrinology journals globally. While not among the highest-impact titles in the field, its consistent indexing and regional influence make it a noteworthy resource for clinicians and researchers, particularly those focused on Central and Eastern European endocrinological practice and research.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.